短模块化子保护无水泥部干的中期结果:一项回顾性研究,至少6年后续研究
Michele Carnovale1, Daniele De Meo2,3, Giovanni Guarascio2,3
1Emergency Department, Policlinico Umberto I University Hospital, Rome, Italy.
Arthroplasty today
|May 6, 2024
概括
这项研究表明,保护部的无水泥短股茎为全关节置换提供了良好的中期生存率. 这些短茎的模块性不会导致机械问题,这使得它们成为活跃患者的可行选择.
科学领域:
- 整形外科手术 整形外科手术
- 生物材料工程是生物材料的工程.
- 重建医学是一种重建医学.
背景情况:
- 保护子的无水泥短茎是高需求患者的全关节置换的选择.
- 关于上一代短茎的模块性存在有限的数据.
- 评估特定的模块化短茎的中期生存和功能结果至关重要.
研究的目的:
- 为了评估一个带有部模块化的部分合体短关节茎的中期存活率.
- 为了评估接受这种植入物的患者的功能状态.
- 调查与短茎模块化相关的潜在机械问题.
主要方法:
- 75名患者 (35-80岁) 的回顾性单中心队列研究,至少6年随访.
- 排除患有神经/风湿性疾病或先前部手术的患者.
- 评估临床结果,并发症,修订和验证的患者报告的结果措施 (WOMHI,哈里斯部得分,SF-12).
主要成果:
- 卡普兰-梅尔分析显示,10年植入物存活率为96.7%,修订率为1.3%.
- 与健康人群相比,患者的哈里斯部分数和SF-12身体分数较低,但SF-12心理分数较高.
- 根据部模块化,没有观察到结果的显著差异.
结论:
- 简短的模块化部保护无水泥部茎是高功能需求患者的合适选择,可保持骨完整性并提供良好的结果.
- 在短茎中模块化子的中期使用没有出现机械并发症.
- 这种植入物设计支持骨的保存,并为全关节整形提供可靠的解决方案.
更多相关视频
09:51The Transition to an Anterior-Based Muscle Sparing Approach Improves Early Postoperative Function but is Associated with a Learning Curve
Published on: September 7, 2022
2.6K
05:30Surgical Approach and Complications of Stand-alone Lateral Trans-Psoas Interbody Fusion
Published on: February 14, 2025
777
相关概念视频
01:27Effects of Chemicals: Overview
Drugs, encompassing various chemical compounds from natural sources, lab synthesis, or genetic engineering, elicit different biological responses in living organisms. Some of these responses are desirable or therapeutic, while others are undesirable. The primary goal of administering a drug is to achieve a therapeutic effect, that is, to address a specific disease or health condition. Any concurrent effects outside of this therapeutic outcome are considered undesirable. These undesirable...
01:23Toxicity Testing in Animals
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...